Humasis, 55,000 Shares Sold Net by Foreigners... Stock Price Down 29.91%

Humasis has ranked among the top searched stocks for 5 days within the past month.

As of 12:32 PM on the 19th, Humasis is trading at 9,120 KRW, up 29.91% from the previous day. This represents a 186.34% increase compared to June 9. Humasis is known as an in vitro diagnostic device company.

Today, foreigners have sold a net 55,000 shares of Humasis, and institutions have sold a net 8,000 shares, according to provisional data. Over the past 5 days, individual investors have bought a net 12,816 shares, while foreigners and institutions have bought a net 58,154 shares and sold a net 410,810 shares, respectively.

On June 18, Humasis became a market topic with the headline "Development of COVID-19 Diagnostic Kit with Celltrion (Part 1)."

[Table] Net Trading Volume of Foreigners and Institutions (Unit: shares)

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.